Basic Information
LncRNA/CircRNA Name | lnc-p23154 |
Synonyms | NA |
Region | NA |
Ensemble | NA |
Refseq | NA |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | oral squamous cell carcinoma |
ICD-0-3 | C06.9 |
Methods | qPCR, Western blot, Luciferase reporter assay, RIP |
Sample | oral squamous cell carcinoma tissues, cell lineS(SCC-15, SCC-25, CAL-27, UM1) |
Expression Pattern | up-regulated |
Function Description | we identified a novel lncRNA lnc-p23154 which is associated with OSCC patient metastasis and the promotion of OSCC cell migration and invasion in vitro and in vivo. In addition, lnc-p23154 is mainly located in the nucleus and binds to the promoter region of miR-378a-3p. Lnc-p23154 is upregulated in OSCC. Additionally, ectopic expression of lnc-p23154 increased the expression of MMP1, CTGF, and EMT-related genes. |
Pubmed ID | 30026052 |
Year | 2018 |
Title | LncRNA-p23154 Promotes the Invasion-Metastasis Potential of Oral Squamous Cell Carcinoma by Regulating Glut1-mediated Glycolysis. |
External Links
Links for lnc-p23154 | GenBank HGNC NONCODE |
Links for oral squamous cell carcinoma | OMIM COSMIC |